NO161313C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.

Info

Publication number
NO161313C
NO161313C NO852810A NO852810A NO161313C NO 161313 C NO161313 C NO 161313C NO 852810 A NO852810 A NO 852810A NO 852810 A NO852810 A NO 852810A NO 161313 C NO161313 C NO 161313C
Authority
NO
Norway
Prior art keywords
fluorallylamine
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO852810A
Other languages
English (en)
Norwegian (no)
Other versions
NO161313B (no
NO852810L (no
Inventor
Ian Alexander Mcdonald
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO852810L publication Critical patent/NO852810L/no
Publication of NO161313B publication Critical patent/NO161313B/no
Publication of NO161313C publication Critical patent/NO161313C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/42—Halogenated unsaturated alcohols acyclic
    • C07C33/423—Halogenated unsaturated alcohols acyclic containing only double bonds as unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO852810A 1984-07-13 1985-07-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. NO161313C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63055684A 1984-07-13 1984-07-13

Publications (3)

Publication Number Publication Date
NO852810L NO852810L (no) 1986-01-14
NO161313B NO161313B (no) 1989-04-24
NO161313C true NO161313C (no) 1989-08-02

Family

ID=24527644

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852810A NO161313C (no) 1984-07-13 1985-07-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.

Country Status (20)

Country Link
EP (1) EP0168013B1 (fr)
JP (1) JPS61257952A (fr)
KR (1) KR900008113B1 (fr)
AR (1) AR240043A1 (fr)
AT (1) ATE32711T1 (fr)
AU (1) AU575973B2 (fr)
CA (1) CA1256453A (fr)
DE (1) DE3561723D1 (fr)
DK (1) DK166878C (fr)
ES (1) ES8603809A1 (fr)
FI (1) FI84057C (fr)
GB (1) GB2162518B (fr)
HU (1) HU195181B (fr)
IE (1) IE58305B1 (fr)
IL (1) IL75739A (fr)
NO (1) NO161313C (fr)
NZ (1) NZ212675A (fr)
PH (1) PH21647A (fr)
PT (1) PT80805B (fr)
ZA (1) ZA855101B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE71933T1 (de) * 1985-12-05 1992-02-15 Merrell Dow Pharma Nichtaromatische fluoralkylamin-mao-inhibitoren.
EP0283168A3 (fr) * 1987-03-16 1989-06-14 American Home Products Corporation Carboxylates de fluoroxiranne
US4822812A (en) * 1987-05-21 1989-04-18 Merrell Dow Pharmaceuticals Inc. β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
SG10201707020TA (en) 2012-05-02 2017-10-30 Boehringer Ingelheim Int Substituted 3-haloallylamine inhibitors of ssao and uses thereof
WO2024044813A1 (fr) * 2022-08-29 2024-03-07 Pharmaxis Ltd. Nouveaux inhibiteurs sélectifs de lysyl oxydases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1027611A (en) * 1962-01-04 1966-04-27 May & Baker Ltd Phenoxy- and phenylthio-alkylamines and acid addition salts thereof
US3205136A (en) * 1962-12-24 1965-09-07 Smith Kline French Lab Antidepressant phenyloxyalkylamines
US3513198A (en) * 1965-10-22 1970-05-19 Hoffmann La Roche Aryloxy- and arylthio-acetylenic amines and the salts thereof
CH480306A (de) * 1966-06-03 1969-10-31 Ciba Geigy Verfahren zur Herstellung von schwefelhaltigen Aminen

Also Published As

Publication number Publication date
NO161313B (no) 1989-04-24
NO852810L (no) 1986-01-14
KR860001048A (ko) 1986-02-22
CA1256453A (fr) 1989-06-27
JPH0530823B2 (fr) 1993-05-11
EP0168013A1 (fr) 1986-01-15
HU195181B (en) 1988-04-28
DK320585A (da) 1986-01-14
PT80805A (en) 1985-08-01
KR900008113B1 (ko) 1990-10-31
PT80805B (pt) 1987-09-18
FI852748L (fi) 1986-01-14
DE3561723D1 (de) 1988-04-07
EP0168013B1 (fr) 1988-03-02
ZA855101B (en) 1986-05-28
FI84057C (fi) 1991-10-10
GB2162518A (en) 1986-02-05
AR240043A1 (es) 1990-01-31
NZ212675A (en) 1988-02-29
GB2162518B (en) 1987-11-18
IL75739A0 (en) 1985-11-29
DK166878B (da) 1993-07-26
ES545111A0 (es) 1986-01-01
JPS61257952A (ja) 1986-11-15
IL75739A (en) 1988-07-31
GB8517454D0 (en) 1985-08-14
FI84057B (fi) 1991-06-28
DK166878C (da) 1993-12-13
DK320585D0 (da) 1985-07-12
AU4466085A (en) 1986-01-16
IE851746L (en) 1986-01-13
HUT38604A (en) 1986-06-30
AU575973B2 (en) 1988-08-11
IE58305B1 (en) 1993-09-08
ES8603809A1 (es) 1986-01-01
PH21647A (en) 1988-01-13
ATE32711T1 (de) 1988-03-15
FI852748A0 (fi) 1985-07-11

Similar Documents

Publication Publication Date Title
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO167284C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001